glycine N-methyltransferase
Dernière mise à jour 6 Aug 2021
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Ajouter aux sources préférées sur Google
La GNMT gene provides instructions for producing the enzyme glycine N-methyltransferase. This enzyme is involved in a multistep process that breaks down the protein building block (amino acid) methionine. Specifically, glycine N-methyltransferase starts a reaction that converts the compounds glycine and S-adenosylmethionine (also called AdoMet) to N-methylglycine and S-adenosylhomocysteine (also called AdoHcy).
Normal function
La GNMT gene provides instructions for producing the enzyme glycine N-methyltransferase. This enzyme is involved in a multistep process that breaks down the protein building block (amino acid) methionine. Specifically, glycine N-methyltransferase starts a reaction that converts the compounds glycine and S-adenosylmethionine (also called AdoMet) to N-methylglycine and S-adenosylhomocysteine (also called AdoHcy).
This reaction also helps to control the relative amounts of AdoMet and AdoHcy. The AdoMet to AdoHcy ratio is important in many body processes, including the regulation of other genes by the addition of methyl groups, consisting of one carbon atom and three hydrogen atoms (methylation). Methylation is important in many cellular functions. These include determining whether the instructions in a particular segment of DNA are carried out, regulating reactions involving proteins and lipids, and controlling the processing of chemicals that relay signals in the nervous system (neurotransmitters).
The glycine N-methyltransferase enzyme is also involved in processing toxic compounds in the liver.
Conditions referring to this gene or chromosome
Other names
Glycine Methyltransferase
Glycine Sarcosine Methyltransferase
Glycine Sarcosine N-Methyltransferase
GNMT_HUMAN
Related patient information and medicines
Patient information leaflet
maladie de Parkinson
maladie de Parkinson is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement disorder with Parkinson's disease symptoms. Par... Sometimes these medicines are used in combination with levodopa in the later stages of.
Medicine leaflet
Entacapone pour la maladie de Parkinson
Your doctor will ... About entacapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Used for Parkinson's disease Also called Comtess®; Combination brands: Stalevo®, Sastravi®, Stanek®, Lecigon® (entacapone with levodopa and carbidopa [ co-careldopa ]) Available as Tablets Parkinson's disease affects the.
Medicine leaflet
Tioguanine
You will be prescribed tioguanine by a doctor who specialises in cancer treatment. Votre médecin vous indiquera combien de comprimés prendre chaque jour et pendant combien de temps les prendre. Tioguanine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and chronic myeloid leukaemia (CML). In particular, tell your doctor.
Medicine leaflet
Tolcapone pour la maladie de Parkinson
You should tell your doctor immediately if you lose your appetite, feel sick or have pain in your tummy (abdomen), develop dark-coloured ur... About tolcapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Utilisé pour médicaments pour la maladie de Parkinson disease Also called Tasmar® Available as Tablets Parkinson's disease affects the.
Medicine leaflet
Mercaptopurine
You will be prescribed mercaptopurine by a specialist cancer doctor. About mercaptopurine Type of medicine An antimetabolite anti-cancer medicine Used for Treatment of leukaemia Also called Xaluprine®; Hanixol® Available as Tablets and oral liquid medicine Leukaemia is a cancer of cells in the bone marrow. Mercaptopurine is a treatment used for.
Medicine leaflet
Noréthistérone pour les règles douloureuses ou abondantes
Noréthistérone est a female hormone treatment. The usual dose is one tablet either two or three times daily. These are ge... About norethisterone Type de médicament Progestogen (female hormone) Used for Painful or heavy periods, particularly when associated with endometriosis Also called Norethindrone (in US); Primolut N®, Utovlan® Available as.
Lectures complémentaires et références
- glycine N-methyltransferase; MedlinePlus, National Library of Medicine.
- Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, Wagner C, Mudd SH. Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis. 2003;26(8):745-59. doi: 10.1023/B:BOLI.0000009978.17777.33.
- Bhat R, Bresnick E. Glycine N-methyltransferase is an example of functional diversity. Role as a polycyclic aromatic hydrocarbon-binding receptor. J Biol Chem. 1997 Aug 22;272(34):21221-6. doi: 10.1074/jbc.272.34.21221.
- Biochemistry (fifth edition, 2002): Methionine Metabolism
- Chen SY, Lin JR, Darbha R, Lin P, Liu TY, Chen YM. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res. 2004 May 15;64(10):3617-23. doi: 10.1158/0008-5472.CAN-03-3726.
- Huang YC, Lee CM, Chen M, Chung MY, Chang YH, Huang WJ, Ho DM, Pan CC, Wu TT, Yang S, Lin MW, Hsieh JT, Chen YM. Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer. Clin Cancer Res. 2007 Mar 1;13(5):1412-20. doi: 10.1158/1078-0432.CCR-06-1551.
- Luka Z, Capdevila A, Mato JM, Wagner C. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res. 2006 Jun;15(3):393-7. doi: 10.1007/s11248-006-0008-1.
- Luka Z, Cerone R, Phillips JA 3rd, Mudd HS, Wagner C. Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism. Hum Genet. 2002 Jan;110(1):68-74. doi: 10.1007/s00439-001-0648-4. Epub 2001 Dec 7.
- Luka Z, Wagner C. Effect of naturally occurring mutations in human glycine N-methyltransferase on activity and conformation. Biochem Biophys Res Commun. 2003 Dec 26;312(4):1067-72. doi: 10.1016/j.bbrc.2003.11.037.
- Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, Lorini R, Watkins D, Matiaszuk N, Rosenblatt DS, Schwahn B, Rozen R, LeGros L, Kotb M, Capdevila A, Luka Z, Finkelstein JD, Tangerman A, Stabler SP, Allen RH, Wagner C. Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis. 2001 Aug;24(4):448-64. doi: 10.1023/a:1010577512912.
- Ogawa H, Gomi T, Takusagawa F, Fujioka M. Structure, function and physiological role of glycine N-methyltransferase. Int J Biochem Cell Biol. 1998 Jan;30(1):13-26. doi: 10.1016/s1357-2725(97)00105-2.
- Smythies JR, Gottfries CG, Regland B. Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review. Biol Psychiatry. 1997 Jan 15;41(2):230-3. doi: 10.1016/S0006-3223(96)00068-6. No abstract available.
- Tseng TL, Shih YP, Huang YC, Wang CK, Chen PH, Chang JG, Yeh KT, Chen YM, Buetow KH. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res. 2003 Feb 1;63(3):647-54.
Participez à la conversation
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.